<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0">
  <channel>
    <title>Press Releases - Quantisnow</title>
    <description>Fastest customizable press release feed in the world.</description>
    <link>https://www.quantisnow.com/news/</link>
    <language>en-us</language>
    <lastBuildDate>Sun, 15 Nov 2026 06:20:19 GMT</lastBuildDate>
    <item>
      <title>BA Investors Who Received Shares of The Boeing Company in Connection to Its Merger with Spirit AeroSystems Can Join Fraud Investigation with SBS Law</title>
      <description>
Schall, Brown &amp; Schwartz LLP (&quot;SBS&quot;), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of The Boeing Company (&quot;Boeing&quot; or &quot;the Company&quot;) (NYSE: BA) who received shares in connection with its December 2025 merger (&quot;the Merger&quot;) with Spirit AeroSystems Holdings, Inc. (&quot;Spirit&quot;) (NYSE:SPR) for violations of the securities laws.


INVESTIGATION DETAILS: The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Following the Merger with Spirit, shares of Boeing have declined significantly.


If you are a shareholder who suffered a loss, cli</description>
      <link>https://www.quantisnow.com/insight/ba-investors-who-received-shares-of-the-boeing-company-in-6791843</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/ba-investors-who-received-shares-of-the-boeing-company-in-6791843</guid>
      <pubDate>Sun, 15 Nov 2026 04:06:00 GMT</pubDate>
    </item>
    <item>
      <title>Hot Wheels Crowns 2026 Legends Tour Winner Following Global Search Across 19 Countries</title>
      <description>

A radically reimagined 1979 Chevrolet El Camino takes the top prize in the 2026 Hot Wheels Legends Tour Presented by Mobil 1



The fan-built car will be transformed into an official 1:64-scale Hot Wheels die-cast sold worldwide



Tampa custom-car builder Matt McEntegart brings the global title back to the U.S. for the first time since 2022



Photos of the 2026 Hot Wheels Legends Tour winner and runners-up can be found HERE.



Mattel, Inc. (NASDAQ:MAT), a leading global play and family entertainment company and owner of one of the world’s most iconic brand portfolios, today announced the 2026 winner of the Hot Wheels™ Legends Tour presented by Mobil 1, the world’s largest traveling car </description>
      <link>https://www.quantisnow.com/insight/hot-wheels-crowns-2026-legends-tour-winner-following-global-search-6791841</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/hot-wheels-crowns-2026-legends-tour-winner-following-global-search-6791841</guid>
      <pubDate>Sat, 14 Nov 2026 17:30:00 GMT</pubDate>
    </item>
    <item>
      <title>Lilly to present new data across Zepbound, Foundayo, EloraTZP and retatrutide at ObesityWeek 2026, moving obesity care beyond the scale</title>
      <description>Phase 2 results showed EloraTZP, an investigational combination of eloralintide and tirzepatide, delivered substantial weight loss and A1C improvements in participants with obesity and type 2 diabetesResults from TRIUMPH-1, TRIUMPH-2 and TRIUMPH-4 demonstrated retatrutide, an investigational triple agonist, reduced obstructive sleep apnea severity and knee osteoarthritis pain in adults with obesityPeople reported Foundayo was simple and easy to use in a new real-world evidence study, while patient-reported outcomes showed that participants treated with eloralintide reported reductions in food noise, food cravings and alcohol consumptionINDIANAPOLIS, Nov. 14, 2026 /PRNewswire/ -- Eli Lilly an</description>
      <link>https://www.quantisnow.com/insight/lilly-to-present-new-data-across-zepbound-foundayo-eloratzp-and-6791839</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/lilly-to-present-new-data-across-zepbound-foundayo-eloratzp-and-6791839</guid>
      <pubDate>Sat, 14 Nov 2026 17:01:00 GMT</pubDate>
    </item>
    <item>
      <title>Amylyx Pharmaceuticals Presents Results from Phase 3 LUCIDITY Clinical Trial of Avexitide in Post-Bariatric Hypoglycemia at ObesityWeek® 2026 Annual Meeting</title>
      <description>

LUCIDITY met its prespecified primary endpoint; avexitide reduced the composite Level 2/3 hypoglycemic event rate by 55% compared to placebo (p=0.000003)





Avexitide showed consistent, highly statistically significant reductions across all prespecified, multiplicity-controlled secondary event-rate endpoints vs. placebo





Avexitide was generally well-tolerated with a favorable safety profile; adverse events during the double-blind treatment period were generally mild to moderate in severity





Company to host an in-person and webcast investor KOL event tomorrow, November 15, at 11:45 AM ET



Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) (&quot;Amylyx&quot; or the &quot;Company&quot;) will present the res</description>
      <link>https://www.quantisnow.com/insight/amylyx-pharmaceuticals-presents-results-from-phase-3-lucidity-clinical-trial-6791838</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/amylyx-pharmaceuticals-presents-results-from-phase-3-lucidity-clinical-trial-6791838</guid>
      <pubDate>Sat, 14 Nov 2026 17:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Rocket Lab Hits 100 Electron Launches, Fastest Commercial Rocket to Reach the Milestone</title>
      <description>LONG BEACH, Calif., Nov.  14, 2026  (GLOBE NEWSWIRE) -- Rocket Lab Corporation (NASDAQ:RKLB), a global leader in launch services and space systems, today announced mission success for its 100th Electron launch, setting a new record for reaching 100 launches faster than any other commercially developed rocket.  &quot;The Mountain God Rises&quot; mission launched from Rocket Lab Launch Complex 1 in New Zealand at 6:30 p.m. on November 14, 2026, deploying the YAMATSUMI-II synthetic aperture radar (SAR) Earth-imaging satellite to a 575km low Earth orbit for the Institute for Q-shu Pioneers of Space, Inc. (iQPS). This mission marks Rocket Lab’s 11th Electron launch for iQPS with 100% mission success since </description>
      <link>https://www.quantisnow.com/insight/rocket-lab-hits-100-electron-launches-fastest-commercial-rocket-to-6791837</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/rocket-lab-hits-100-electron-launches-fastest-commercial-rocket-to-6791837</guid>
      <pubDate>Sat, 14 Nov 2026 07:02:55 GMT</pubDate>
    </item>
    <item>
      <title>CORRECTION: Axe Compute to Host Q3 2026 Financial Results Conference Call</title>
      <description>MIAMI, Nov.  13, 2026  (GLOBE NEWSWIRE) -- In a release issued under the same headline on November 11th by Axe Compute (NASDAQ:AGPU), please note that the date of the conference call in the first paragraph was incorrect. It should have been November 17, 2026, instead of November 16, 2026. The corrected release follows:  Axe Compute (NASDAQ:AGPU), a neocloud AI infrastructure company delivering dedicated, bare-metal GPU compute and large-scale AI factory build-outs at global scale, today announced it will hold a conference call and webcast to review financial results for the third quarter ended September 30, 2026, before market open on Tuesday, November 17, 2026.  Speakers on the call will be</description>
      <link>https://www.quantisnow.com/insight/correction-axe-compute-to-host-q3-2026-financial-results-conference-6791836</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/correction-axe-compute-to-host-q3-2026-financial-results-conference-6791836</guid>
      <pubDate>Sat, 14 Nov 2026 04:05:00 GMT</pubDate>
    </item>
    <item>
      <title>Zai Lab Announces First-Time Inclusion of KarXT and VYVGART Hytrulo® in China’s 2026 National Reimbursement Drug List, Expanding Access to Key Growth Products</title>
      <description>
Zai Lab Limited (NASDAQ:ZLAB, HKEX: 9688)), an innovation-driven, global biopharma company, today announced that five of its commercial medicines in China have been included in the country’s 2026 National Reimbursement Drug List (NRDL). The update includes two first-time listings, expanding patient access to treatments for gMG and schizophrenia, and three renewals, which maintain access across oncology and infectious disease.


Zai Lab Products Newly Added or Renewed in 2026 NRDL:


First-time listings:



VYVGART Hytrulo® (efgartigimod alfa, subcutaneous injection): for the treatment of adult patients with anti-acetylcholine receptor (AChR) antibody-positive generalized myasthenia gravis (</description>
      <link>https://www.quantisnow.com/insight/zai-lab-announces-first-time-inclusion-of-karxt-and-vyvgart-hytrulo-6791835</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/zai-lab-announces-first-time-inclusion-of-karxt-and-vyvgart-hytrulo-6791835</guid>
      <pubDate>Sat, 14 Nov 2026 03:26:00 GMT</pubDate>
    </item>
    <item>
      <title>Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)</title>
      <description>BRANFORD, Conn., Nov.  13, 2026  (GLOBE NEWSWIRE) -- Quantum-Si Incorporated (NASDAQ:QSI) (&quot;Quantum-Si,&quot; &quot;QSI&quot; or the &quot;Company&quot;), a proteomics company redefining protein analysis through single-molecule protein sequencing, today announced that the Compensation Committee of Quantum-Si’s Board of Directors has granted 495,335 restricted stock units (&quot;RSUs&quot;) to new employees under the Company’s previously adopted Quantum-Si Incorporated 2023 Inducement Equity Incentive Plan, as amended (the &quot;2023 Inducement Plan&quot;). The RSUs were granted as an inducement material to the new employees becoming an employee of Quantum-Si in accordance with Nasdaq Listing Rule 5635(c)(4).  The 2023 Inducement Plan i</description>
      <link>https://www.quantisnow.com/insight/quantum-si-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-6791761</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/quantum-si-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-6791761</guid>
      <pubDate>Sat, 14 Nov 2026 01:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Cohen &amp; Steers Announces Changes to Realty Indexes</title>
      <description>NEW YORK, Nov. 13, 2026 /PRNewswire/ -- Cohen &amp; Steers, Inc. (NYSE:CNS) announced today pending changes to its Realty Majors Portfolio Index (RMP), Global Realty Majors Portfolio Index (GRM) and International Realty Majors Portfolio Index (IRP), effective as of the close of business on November 20, 2026.
Cohen &amp; Steers Realty Majors Portfolio Index (RMP)Added component (symbol)Removed component (symbol)American Healthcare REIT, Inc. (AHR.US)VICI Properties, Inc. (VICI.US)Cohen &amp; Steers Global Realty Majors Portfolio Index (GRM)Added component (symbol)Removed component (symbol)American Healthcare REIT, Inc. (AHR.US)VICI Properties, Inc. (VICI.US)Great Portland Estates plc (GPE.LN)Derwent Lond</description>
      <link>https://www.quantisnow.com/insight/cohen-steers-announces-changes-to-realty-indexes-6791718</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/cohen-steers-announces-changes-to-realty-indexes-6791718</guid>
      <pubDate>Sat, 14 Nov 2026 00:29:00 GMT</pubDate>
    </item>
    <item>
      <title>/C O R R E C T I O N - BTQ Technologies Corp./</title>
      <description>In the news release, BTQ Technologies to Host Live Webinar on Q3 2026 Financial Results and General Corporate Update, issued Nov. 13, 2026 by BTQ Technologies Corp. over PR Newswire, we are advised by the company that changes have been made. The complete, corrected release follows: BTQ Technologies to Host Live Webinar on Q3 2026 Financial Results and General Corporate Update
VANCOUVER, BC, Nov. 13, 2026 /PRNewswire/ -- BTQ Technologies Corp. (&quot;BTQ&quot; or the &quot;Company&quot;) (NASDAQ:BTQ) (CBOE CA: BTQ),  a global technology company building the trust infrastructure for the quantum era, is pleased to announce that it will hold a shareholder call on Friday, November 17, 2026, at 11:00 a.m. EST to disc</description>
      <link>https://www.quantisnow.com/insight/c-o-r-r-e-c-t-i-o-n-6791662</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/c-o-r-r-e-c-t-i-o-n-6791662</guid>
      <pubDate>Fri, 13 Nov 2026 22:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Dana Announces Pricing, Expiration and Results of Tender Offers for Any and All of its Outstanding 4.250% Senior Notes due 2030 and 4.500% Senior Notes due 2032</title>
      <description>MAUMEE, Ohio, Nov. 13, 2026 /PRNewswire/ -- Dana Incorporated (NYSE:DAN) (&quot;Dana&quot; or the &quot;Company&quot;) announced today the pricing, expiration and results of its tender offers to purchase for cash any and all of its outstanding 4.250% Senior Notes due 2030 (the &quot;2030 Notes&quot;) and 4.500% Senior Notes due 2032 (the &quot;2032 Notes&quot; and, together with the 2030 Notes, the &quot;Notes&quot;). The tender offers (each, an &quot;Offer&quot; and, together, the &quot;Offers&quot;) were made pursuant to the Offer to Purchase, dated November 6, 2026 (the &quot;Offer to Purchase&quot;). The Offers expired at 5:00 p.m., New York City time, on November 13, 2026 (the &quot;Expiration Date&quot;).
    
                
                    
                
    
Acco</description>
      <link>https://www.quantisnow.com/insight/dana-announces-pricing-expiration-and-results-of-tender-offers-for-6791660</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/dana-announces-pricing-expiration-and-results-of-tender-offers-for-6791660</guid>
      <pubDate>Fri, 13 Nov 2026 23:42:00 GMT</pubDate>
    </item>
    <item>
      <title>Perioperative IMFINZI® (durvalumab) approved in the US in novel regimen with neoadjuvant enfortumab vedotin-ejfv for patients with muscle-invasive bladder cancer</title>
      <description>
Based on VOLGA Phase III trial data which showed a 49% reduction in risk of recurrence and a 42% reduction in risk of death, with a manageable safety profile


Approval reinforces potential of IMFINZI as an immunotherapy backbone across muscle-invasive and non-muscle-invasive bladder cancer​


AstraZeneca’s ​IMFINZI® (durvalumab)​ in combination with enfortumab vedotin-ejfv (EV) as neoadjuvant treatment, followed by IMFINZI monotherapy as adjuvant treatment after radical cystectomy (surgery to remove the bladder), has been approved in the US for the treatment of adult patients with muscle-invasive bladder cancer (MIBC) who are ineligible for or have refused cisplatin-based chemotherapy.


T</description>
      <link>https://www.quantisnow.com/insight/perioperative-imfinzi-durvalumab-approved-in-the-us-in-novel-regimen-6791653</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/perioperative-imfinzi-durvalumab-approved-in-the-us-in-novel-regimen-6791653</guid>
      <pubDate>Fri, 13 Nov 2026 23:39:00 GMT</pubDate>
    </item>
    <item>
      <title>Bloom Energy Supports Louisiana Disaster Relief Ahead of Texas-LSU Matchup</title>
      <description>
As Baton Rouge gets ready for the Texas-LSU matchup, Bloom Energy is joining the community off the field to support two organizations making a difference for families across Louisiana.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261113756487/en/
On Friday, Bloom Energy visited Baton Rouge Fire Station 12 to recognize the work of the Baton Rouge Area Foundation and Civic Collaborative Foundation, two organizations helping strengthen communities and support Louisianans in times of need. As part of the event, Bloom Energy presented each organization with a $10,000 donation.


&quot;Keeping communities safe depends on the people and o</description>
      <link>https://www.quantisnow.com/insight/bloom-energy-supports-louisiana-disaster-relief-ahead-of-texas-lsu-matchup-6791652</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/bloom-energy-supports-louisiana-disaster-relief-ahead-of-texas-lsu-matchup-6791652</guid>
      <pubDate>Fri, 13 Nov 2026 23:38:00 GMT</pubDate>
    </item>
    <item>
      <title>Chime Financial Set to Join S&amp;P MidCap 400</title>
      <description>NEW YORK, Nov. 13, 2026 /PRNewswire/ -- Chime Financial Inc. (NASD: CHYM) will replace NorthWestern Energy Group Inc. (NASD: NWE) in the S&amp;P MidCap 400 effective prior to the opening of trading on Wednesday, November 18. S&amp;P MidCap 400 constituent Black Hills Corp. (NYSE:BKH) is acquiring NorthWestern Energy Group in a deal expected to be completed today. Post-merger, the combined company will remain in the S&amp;P MidCap 400 and will be renamed Bright Horizon Energy Corp. (NYSE:HZN).
Following is a summary of the changes that will take place prior to the open of trading on the effective date:Effective DateIndex Name       ActionCompany NameTickerGICS SectorNovember 18, 2026     S&amp;P MidCap 400  </description>
      <link>https://www.quantisnow.com/insight/chime-financial-set-to-join-sp-midcap-400-6791634</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/chime-financial-set-to-join-sp-midcap-400-6791634</guid>
      <pubDate>Fri, 13 Nov 2026 23:18:00 GMT</pubDate>
    </item>
    <item>
      <title>Service Properties Trust Receives Statement of Support from Shareholder Flat Footed LLC</title>
      <description>
Service Properties Trust (NASDAQ:SVC) (&quot;SVC&quot; or the &quot;Company&quot;) today announced that Flat Footed LLC (&quot;Flat Footed&quot;), an SVC institutional shareholder, has expressed support for the plan announced earlier today by SVC’s Board of Trustees to transition SVC into a pure-play triple net lease REIT.


Marc Andersen, Co-Founder and Managing Member of Flat Footed LLC, made the following statement:


&quot;Given the capital recently deployed into the retained hotel portfolio and the commitment of SVC’s Board to convert the Company into a triple net lease REIT over the next two years, Flat Footed supports SVC’s decision to monetize the hotel portfolio at a pace that allows for maximum value realization. O</description>
      <link>https://www.quantisnow.com/insight/service-properties-trust-receives-statement-of-support-from-shareholder-flat-6791612</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/service-properties-trust-receives-statement-of-support-from-shareholder-flat-6791612</guid>
      <pubDate>Fri, 13 Nov 2026 23:01:00 GMT</pubDate>
    </item>
    <item>
      <title>Organigram Provides NASDAQ Listing Update</title>
      <description>
The Notification has no immediate effect on the listing or trading of the Company&apos;s common shares on the Nasdaq Global Select Market.


Organigram Global Inc. (NASDAQ:OGI) (TSX:OGI) (the &quot;Company&quot; or &quot;Organigram&quot;), Canada&apos;s #1 cannabis company by market share¹ and a growing global cannabis platform, today announced that on November 11, 2026, it received notification (the &quot;Notification&quot;) from The Nasdaq Stock Market LLC (&quot;Nasdaq&quot;) that it is not in compliance with the minimum bid price requirement under Nasdaq Listing Rule 5450(a)(1) for continued listing on the Nasdaq Global Select Market. The Notification was issued because the closing bid price of the Company&apos;s common shares was below US$</description>
      <link>https://www.quantisnow.com/insight/organigram-provides-nasdaq-listing-update-6791604</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/organigram-provides-nasdaq-listing-update-6791604</guid>
      <pubDate>Fri, 13 Nov 2026 23:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Syntec Optics&apos; (Nasdaq: OPTX) Q3 Hits All Time High Revenue, Profits Grow to Double-Digit Adj EBITDA, and Net Income Surges Positive</title>
      <description>ROCHESTER, NEW YORK, Nov.  13, 2026  (GLOBE NEWSWIRE) -- Syntec Optics Holdings, Inc. (NASDAQ:OPTX) (&quot;Syntec Optics&quot; or the &quot;Company&quot;), a provider of deep-tech products to industry pioneers connecting and protecting the world, today announced financial results for the third quarter ended September 30, 2026. Supporting mission-critical applications ranging from low-Earth-orbit satellites and bipartisan connected-battlefield defense platforms to life sciences, Syntec delivered an all-time high revenue of $8.5 million, up 23% year over year, and net income improved by $1.6 million to a positive net income of $0.2 million, compared with a $1.4 million net loss in the prior-year quarter. The quar</description>
      <link>https://www.quantisnow.com/insight/syntec-optics-nasdaq-optx-q3-hits-all-time-high-revenue-6791602</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/syntec-optics-nasdaq-optx-q3-hits-all-time-high-revenue-6791602</guid>
      <pubDate>Fri, 13 Nov 2026 22:57:57 GMT</pubDate>
    </item>
    <item>
      <title>The NYSE Welcomes vVARDIS as a Publicly Listed Company</title>
      <description>NEW YORK, Nov. 13, 2026 /CNW/ -- vVARDIS (NYSE:VVVV) co-founders Dr. Haley Abivardi and Dr. Goly Abivardi aim to reshape the future of dental care with a drill-free treatment for the world&apos;s #1 non-communicable disease: cavities.
    
                
    
vVARDIS Solves a Problem that Millions FaceTooth decay affects billions of people worldwide, and dental anxiety keeps millions from getting the care they need.vVARDIS is a Swiss dental technology company focused on changing the way early tooth decay is treated.vVARDIS has introduced a new approach that aims to treat decay earlier and more comfortably for patients.Its flagship product, Curodont® Repair Fluoride Plus, uses proprietary peptid</description>
      <link>https://www.quantisnow.com/insight/the-nyse-welcomes-vvardis-as-a-publicly-listed-company-6791601</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/the-nyse-welcomes-vvardis-as-a-publicly-listed-company-6791601</guid>
      <pubDate>Fri, 13 Nov 2026 22:56:00 GMT</pubDate>
    </item>
    <item>
      <title>Kentucky Power Files Plans to Deliver Customer Savings and Advance Kentucky&apos;s Economic Future</title>
      <description>Filings seek approval for new generation and transmission infrastructure to support growth while delivering benefits for existing customersASHLAND, Ky., Nov. 13, 2026 /PRNewswire/ -- Kentucky Power today filed plans with the Kentucky Public Service Commission (PSC) to bring significant new economic development to eastern Kentucky while delivering direct financial benefits to existing customers and protecting them from the costs of serving new large-load customers.The filings would support TeraWulf&apos;s planned Muskie Data Campus in Grayson, Kentucky, and the infrastructure needed to serve it. Over the life of the agreement, the project is expected to provide Kentucky Power customers with more t</description>
      <link>https://www.quantisnow.com/insight/kentucky-power-files-plans-to-deliver-customer-savings-and-advance-6791597</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/kentucky-power-files-plans-to-deliver-customer-savings-and-advance-6791597</guid>
      <pubDate>Fri, 13 Nov 2026 22:55:00 GMT</pubDate>
    </item>
    <item>
      <title>Trinity Place Holdings Inc. Reports Third Quarter Financial Results</title>
      <description>
Trinity Place Holdings Inc. (OTC:TPHS) (the &quot;Company,&quot; &quot;we,&quot; &quot;our,&quot; or &quot;us&quot;) today announced operating results for the third quarter ended September 30, 2026.


The Company is an intellectual property holding, investment, and commercialization company. We own and control a portfolio of intellectual property assets focused on the consumer sector, a legacy of our predecessor, Syms Corp. (&quot;Syms&quot;), including FilenesBasement.com, as well as the intellectual property associated with the Running of the Brides® event and the An Educated Consumer is Our Best Customer® slogan. Our strategy today centers on monetizing these assets through brand licensing, e-commerce initiatives, strategic partnerships</description>
      <link>https://www.quantisnow.com/insight/trinity-place-holdings-inc-reports-third-quarter-financial-results-6791589</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/trinity-place-holdings-inc-reports-third-quarter-financial-results-6791589</guid>
      <pubDate>Fri, 13 Nov 2026 22:49:00 GMT</pubDate>
    </item>
    <item>
      <title>Perpetua Resources Announces Third Quarter 2026 Financial Results and Provides Project Update</title>
      <description>BOISE, Idaho, Nov. 13, 2026 /CNW/ -- Perpetua Resources Corp. (NASDAQ:PPTA) (TSX:PPTA) (&quot;Perpetua Resources&quot; or &quot;Perpetua&quot; or the &quot;Company&quot;) announced the filing of its unaudited condensed consolidated financial results for the period ended September 30, 2026. For details, please see the Company&apos;s related filing available on EDGAR and SEDAR+.
    
                
                    
                
    
&quot;Perpetua made significant progress in Q3 2026,&quot; said Jon Cherry, President and CEO of Perpetua Resources. &quot;From advancing temporary and permanent worker housing to pioneering new access into the site, our Stibnite Gold Project is well positioned to move forward with disciplined execution.</description>
      <link>https://www.quantisnow.com/insight/perpetua-resources-announces-third-quarter-2026-financial-results-and-provides-6791577</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/perpetua-resources-announces-third-quarter-2026-financial-results-and-provides-6791577</guid>
      <pubDate>Fri, 13 Nov 2026 22:40:00 GMT</pubDate>
    </item>
    <item>
      <title>BMO Announces Estimated Annual Reinvested Distributions for BMO Exchange Traded Funds and ETF Series of BMO Mutual Funds</title>
      <description>TORONTO, Nov. 13, 2026 /CNW/ -- BMO Asset Management Inc. and BMO Investments Inc. today announced the estimated 2026 annual reinvested distributions for BMO Exchange Traded Funds (BMO ETFs) and ETF Series of BMO Mutual Funds (ETF Series)1. These annual reinvested distributions generally represent realized capital gains and special income within the BMO ETFs and ETF Series, and are paid to unitholders, as required, to ensure that the BMO ETFs and ETF Series are not liable for ordinary income tax.
Unitholders of record at close of business on December 30, 2026, will receive the 2026 annual reinvested distributions. The final year-end distribution amounts, as well as the ongoing cash distribut</description>
      <link>https://www.quantisnow.com/insight/bmo-announces-estimated-annual-reinvested-distributions-for-bmo-exchange-traded-6791555</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/bmo-announces-estimated-annual-reinvested-distributions-for-bmo-exchange-traded-6791555</guid>
      <pubDate>Fri, 13 Nov 2026 22:35:00 GMT</pubDate>
    </item>
    <item>
      <title>Cerenome Reports Third Quarter 2026 Financial Results and Business Highlights Featuring REYOBIQ ReSPECT- LM Data and CNSide Commercial and Reimbursement Progress</title>
      <description>HOUSTON, Nov.  13, 2026  (GLOBE NEWSWIRE) -- Cerenome, Inc. (NASDAQ:CNSY) (&quot;Cerenome&quot; or the &quot;Company&quot;), a CNS oncology company advancing an integrated platform that combines precision diagnostics, targeted radiopharmaceuticals, and artificial intelligence, announces financial results for the third quarter ended September 30, 2026, and provides an overview of recent business progress.    &quot;Recognition of our first quarter of CNSide® diagnostic revenue and commercial payments beginning in October is a tremendous landmark,&quot; said Marc H. Hedrick, M.D., Cerenome’s President and Chief Executive Officer. &quot;Furthermore, our payer universe continues to expand with now about 80% of U.S. private payers </description>
      <link>https://www.quantisnow.com/insight/cerenome-reports-third-quarter-2026-financial-results-and-business-highlights-6791452</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/cerenome-reports-third-quarter-2026-financial-results-and-business-highlights-6791452</guid>
      <pubDate>Fri, 13 Nov 2026 22:19:23 GMT</pubDate>
    </item>
    <item>
      <title>BeyondSpring Reports Third-Quarter 2026 Financial Results and Provides Corporate Update</title>
      <description>FDA Fast Track Designation for Plinabulin plus docetaxel marks key regulatory milestone in DUBLIN-4 study population of Post-ICI Non-Squamous NSCLC with no actionable genomic alteration (AGA)  Strategic transaction with Biolin provides data from approximately half of DUBLIN-4’s 442 patients and supports the planned interim analysis at 221 PFS events  FLORHAM PARK, N.J., Nov.  13, 2026  (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ:BYSI) (&quot;BeyondSpring&quot; or the &quot;Company&quot;), a clinical-stage company developing innovative therapies for the treatment of cancer and other diseases, today announced its financial results for the quarter ended September 30, 2026, and provided a corporate update highlig</description>
      <link>https://www.quantisnow.com/insight/beyondspring-reports-third-quarter-2026-financial-results-and-provides-corporate-update-6791414</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/beyondspring-reports-third-quarter-2026-financial-results-and-provides-corporate-update-6791414</guid>
      <pubDate>Fri, 13 Nov 2026 22:15:39 GMT</pubDate>
    </item>
    <item>
      <title>Accuray Closes TCW Transaction, Strengthening Balance Sheet to Support Long-Term Value Growth</title>
      <description>MADISON, Wis., Nov. 13, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ:ARAY) today announced that it has completed its financing transaction with TCW Asset Management Company LLC (&quot;TCW&quot;), the company&apos;s primary lender and largest shareholder. The transaction significantly reduces Accuray&apos;s debt, adds new capital and waives certain financial covenants through December 31, 2027. Together, these steps put the company&apos;s balance sheet on a firmer footing as it carries out the next phase of its previously announced strategic transformation.
    
                
                    
                
    
The closing follows stockholder approval of all transaction-related proposals at Accuray&apos;s S</description>
      <link>https://www.quantisnow.com/insight/accuray-closes-tcw-transaction-strengthening-balance-sheet-to-support-long-term-6791390</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/accuray-closes-tcw-transaction-strengthening-balance-sheet-to-support-long-term-6791390</guid>
      <pubDate>Fri, 13 Nov 2026 22:10:00 GMT</pubDate>
    </item>
    <item>
      <title>IM Cannabis Corp. Announces Third Quarter 2026 Financial Results</title>
      <description>VANCOUVER, BC and GLIL YAM, Israel, Nov. 13, 2026 /PRNewswire/ -- IM Cannabis Corp. (the &quot;Company&quot;) (NASDAQ:IMCC) announced its financial results for the third quarter and first nine months ended September 30, 2026.
    
                
                    
                
    
For the third quarter of 2026, revenue totaled C$1.65 million, compared to C$5.08 million in the same period last year. The Company reported a gross loss of C$35,000 and a total net loss of C$7.08 million, compared to a net loss of C$3.87 million in the third quarter of 2025. For the first nine months of 2026, revenue totaled C$8.96 million, compared to C$15.77 million in the corresponding period of 2025, while tota</description>
      <link>https://www.quantisnow.com/insight/im-cannabis-corp-announces-third-quarter-2026-financial-results-6791389</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/im-cannabis-corp-announces-third-quarter-2026-financial-results-6791389</guid>
      <pubDate>Fri, 13 Nov 2026 22:10:00 GMT</pubDate>
    </item>
    <item>
      <title>Fly-E Group, Inc. Announces Second Quarter and First Half of Fiscal Year 2027 Financial Results</title>
      <description>NEW YORK, Nov. 13, 2026 /PRNewswire/ -- Fly-E Group, Inc. (NASDAQ:FLYE) (&quot;Fly-E&quot; or the &quot;Company&quot;), an electric vehicle company engaged in designing, installing, selling, and renting smart electric motorcycles, electric bikes, and electric scooters, today announced its unaudited financial results for the second quarter and first half of fiscal year 2027 ended September 30, 2026.
Second quarter of Fiscal Year 2027 Financial SummaryNet revenues were $2.6 million, compared to $3.9 million in the same period last year.Gross profit was $0.2 million, compared to $1.0 million in the same period last year.Gross margin was 8.1%, compared to 25.0% in the same period last year.Net Loss was $1.7 million</description>
      <link>https://www.quantisnow.com/insight/fly-e-group-inc-announces-second-quarter-and-first-half-of-6791334</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/fly-e-group-inc-announces-second-quarter-and-first-half-of-6791334</guid>
      <pubDate>Fri, 13 Nov 2026 22:05:00 GMT</pubDate>
    </item>
    <item>
      <title>Cheetah Net Supply Chain Service Inc. Announces Third Quarter 2026 Results and Provides Corporate Update</title>
      <description>IRVINE, Calif., Nov.  13, 2026  (GLOBE NEWSWIRE) -- Cheetah Net Supply Chain Service Inc. (&quot;Cheetah&quot; or the &quot;Company&quot;) (Nasdaq CM: CTNT), a provider of logistics and warehousing services and international trading services, today reported results for the quarter ended September 30, 2026 and provided a corporate update.  For the quarter ended September 30, 2026, the Company reported total revenue of $3,557,805, compared to $361,935 in the same period in 2025, representing an increase of $3,195,870, or 883.0%. The Company recorded an operating loss of $821,890 for the quarter ended September 30, 2026, compared to an operating loss of $1,564,479 in the same period in 2025, representing a decreas</description>
      <link>https://www.quantisnow.com/insight/cheetah-net-supply-chain-service-inc-announces-third-quarter-2026-6791333</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/cheetah-net-supply-chain-service-inc-announces-third-quarter-2026-6791333</guid>
      <pubDate>Fri, 13 Nov 2026 22:05:00 GMT</pubDate>
    </item>
    <item>
      <title>Calidi Biotherapeutics Reports Third Quarter 2026 Financial Results and Recent Business Highlights</title>
      <description> -     Continued to advance the development of CLD-401 towards the clinic  -      Presented new CLD-401 data and in situ TCE platform advances at the ESMO Congress 2026  -      Received $1.2 million gross proceeds from at-the-market registered direct offering  -      Reduced general and administrative expenses by $1.0 million, or 39%, in the third quarter of 2026 versus the same period in the prior year  SAN DIEGO, Nov.  13, 2026  (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE:CLDI) (&quot;Calidi&quot; or the &quot;Company&quot;), a biotechnology company pioneering the development of targeted genetic medicines, today reported financial and operating results for the three months ended September 30, 2026,</description>
      <link>https://www.quantisnow.com/insight/calidi-biotherapeutics-reports-third-quarter-2026-financial-results-and-recent-6791324</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/calidi-biotherapeutics-reports-third-quarter-2026-financial-results-and-recent-6791324</guid>
      <pubDate>Fri, 13 Nov 2026 22:03:44 GMT</pubDate>
    </item>
    <item>
      <title>BTQ Technologies to Host Live Webinar on Q3 2026 Financial Results and General Corporate Update</title>
      <description>VANCOUVER, BC, Nov. 13, 2026 /CNW/ -- BTQ Technologies Corp. (&quot;BTQ&quot; or the &quot;Company&quot;) (NASDAQ:BTQ) (CBOE CA: BTQ),  a global technology company building the trust infrastructure for the quantum era, is pleased to announce that it will hold a shareholder call on Friday, August 14, 2026, at 12:00 p.m. EST to discuss its quarterly financial results and provide a general corporate update. The call will follow the release of the Company&apos;s Q3 2026 financial statements, which will be issued after market close on Monday, November 16, 2026.
    
                
                    
                
    
IMPORTANT – To register for the webcast see below:When: November 17, 2026Time: 11:00 AM Eastern T</description>
      <link>https://www.quantisnow.com/insight/btq-technologies-to-host-live-webinar-on-q3-2026-financial-6791274</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/btq-technologies-to-host-live-webinar-on-q3-2026-financial-6791274</guid>
      <pubDate>Fri, 13 Nov 2026 22:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Sports Illustrated Resorts Opens in Nashville, Launching a National Sports Hospitality Brand</title>
      <description>
The first of many planned destinations is drawing a new generation of fans


Travel + Leisure Co. (NYSE:TNL), a leading leisure travel and hospitality company, officially opens Sports Illustrated Resorts Nashville today, launching a national hospitality brand built around the games, teams and events fans love. The 185-suite resort on Music Row, one mile from downtown Nashville and the Gulch, is the first of four announced destinations totaling more than 800 suites and units.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261113177604/en/Travel + Leisure Co., a leading leisure travel and hospitality company, officially opens Spor</description>
      <link>https://www.quantisnow.com/insight/sports-illustrated-resorts-opens-in-nashville-launching-a-national-sports-6791272</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/sports-illustrated-resorts-opens-in-nashville-launching-a-national-sports-6791272</guid>
      <pubDate>Fri, 13 Nov 2026 22:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Datavault AI Receives Notice of Nasdaq Trading Suspension; Common Stock Eligible to Trade on OTC Markets</title>
      <description>Datavault AI Inc. (&quot;Datavault&quot; or the &quot;Company&quot;) (OTC:DVLT), today announced that the Company expects its common stock will be eligible to trade on the over-the-counter market (&quot;OTC Markets&quot;) effective with the open of the market on November 17, 2026. The move to OTC Markets follows Nasdaq’s decision to suspend trading in the Company’s common stock effective November 17, 2026, due to the Company’s non-compliance with Nasdaq’s $1.00 minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) and the &quot;low stock price&quot; rule set forth in Nasdaq Listing Rule 5810(c)(3)(A)(iii), which requires a suspension of Nasdaq trading for an issuer that evidences a closing bid price of less tha</description>
      <link>https://www.quantisnow.com/insight/datavault-ai-receives-notice-of-nasdaq-trading-suspension-common-stock-6791271</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/datavault-ai-receives-notice-of-nasdaq-trading-suspension-common-stock-6791271</guid>
      <pubDate>Fri, 13 Nov 2026 22:00:00 GMT</pubDate>
    </item>
    <item>
      <title>ArrowMark Financial Corp. Announces Monthly Cash Distribution of $0.15 per Share for November 2026</title>
      <description>DENVER, Nov.  13, 2026  (GLOBE NEWSWIRE) -- ArrowMark Financial Corp. (NASDAQ:BANX) (&quot;ArrowMark Financial&quot; or the &quot;Company&quot;), an SEC registered closed-end management investment company, today announced that its Board of Directors has declared a monthly cash distribution of $0.15 per share for November 2026. The total distribution of $0.15 per share will be payable on November 30, 2026, to shareholders of record on November 23, 2026.  About ArrowMark Financial Corp.   ArrowMark Financial Corp. is an SEC registered non-diversified, closed-end fund listed on the NASDAQ Global Select Market under the symbol &quot;BANX.&quot; Its investment objective is to provide shareholders with current income. The Fund</description>
      <link>https://www.quantisnow.com/insight/arrowmark-financial-corp-announces-monthly-cash-distribution-of-015-per-6791270</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/arrowmark-financial-corp-announces-monthly-cash-distribution-of-015-per-6791270</guid>
      <pubDate>Fri, 13 Nov 2026 22:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Liberty Defense Clarifies Previously Announced Credit Facility and Term Loan</title>
      <description>WILMINGTON, Mass., Nov.  13, 2026  (GLOBE NEWSWIRE) -- Liberty Defense Holdings Ltd. (&quot;Liberty&quot; or the &quot;Company&quot;) (NASDAQ:DETX, TSXV:SCAN), a leading provider of AI-based next-generation detection solutions for concealed weapons and threats, issues this clarifying news release requested by the TSX Venture Exchange (the &quot;TSXV&quot;) regarding a credit facility and term loan entered into by the Company with PFF, LLC (&quot;Parabilis&quot;) previously announced on August 22, 2024.  The Company’s wholly-owned subsidiary Liberty Defense Technologies Inc. (the &quot;Subsidiary&quot;) and Parabilis entered into a Loan and Security Agreement dated August 19, 2024, as amended March 15, 2025, July 15, 2025, August 14, 2025 an</description>
      <link>https://www.quantisnow.com/insight/liberty-defense-clarifies-previously-announced-credit-facility-and-term-loan-6791269</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/liberty-defense-clarifies-previously-announced-credit-facility-and-term-loan-6791269</guid>
      <pubDate>Fri, 13 Nov 2026 22:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Stardust Power Reports Q3 2026 Financial Results and Business Update</title>
      <description>GREENWICH, Conn., Nov.  13, 2026  (GLOBE NEWSWIRE) -- Stardust Power Inc. (&quot;Stardust Power&quot; or the &quot;Company&quot;), an American developer of battery-grade lithium carbonate, today announced its financial results for the quarter ended September 30, 2026, and provided an update on its corporate developments and the development of its proposed lithium refinery project in Muskogee, Oklahoma.  Third Quarter 2026 Business Updates and Subsequent Events:  Muskogee Lithium Refinery: The Company continued to test soil core samples taken from its Muskogee, Oklahoma site as part of the Company’s third-party geotechnical evaluation of site conditions. The proposed refinery project is designed for a nameplate </description>
      <link>https://www.quantisnow.com/insight/stardust-power-reports-q3-2026-financial-results-and-business-update-6791268</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/stardust-power-reports-q3-2026-financial-results-and-business-update-6791268</guid>
      <pubDate>Fri, 13 Nov 2026 22:00:00 GMT</pubDate>
    </item>
    <item>
      <title>byNordic Acquisition Corporation Announces Extension of Deadline to Complete Business Combination</title>
      <description>New York, NY, Nov.  13, 2026  (GLOBE NEWSWIRE) --  byNordic Acquisition Corporation (&quot;BYNO&quot; or the &quot;Company&quot;), a special purpose acquisition company, announced today that the Company has timely deposited into the Company’s trust account (the &quot;Trust Account&quot;), an aggregate of $8,850.20, in order to extend the period of time the Company has to complete a business combination for an additional one (1) month period, from November 12, 2026 to December 12, 2026 (the &quot;Extension&quot;). The Extension is the fourth of up to twelve (12) one-month extensions permitted under the August 7, 2026 amendment to the Company’s Amended and Restated Certificate of Incorporation that allows the Company’s board of dire</description>
      <link>https://www.quantisnow.com/insight/bynordic-acquisition-corporation-announces-extension-of-deadline-to-complete-business-6791259</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/bynordic-acquisition-corporation-announces-extension-of-deadline-to-complete-business-6791259</guid>
      <pubDate>Fri, 13 Nov 2026 21:57:30 GMT</pubDate>
    </item>
    <item>
      <title>WHITEHORSE FINANCE, INC. TO REDEEM 7.875% NOTES DUE 2028</title>
      <description>NEW YORK, Nov. 13, 2026 /PRNewswire/ -- WhiteHorse Finance, Inc. (&quot;WhiteHorse Finance&quot; or the &quot;Company&quot;) (NASDAQ:WHF) announced that it will redeem its 7.875% Notes due 2028 (NASDAQ:WHFCL) (the &quot;Notes&quot;). The Company will redeem 100%, or $34,500,000 aggregate principal amount, of the issued and outstanding Notes on December 15, 2026 (the &quot;Redemption Date&quot;), following which the Notes will be delisted from the Nasdaq Global Select Market. The redemption price per Note will be $25 plus accrued and unpaid interest otherwise payable for the then-current quarterly interest period accrued to, but excluding, the Redemption Date. The regular quarterly interest installment due on December 15, 2026 will</description>
      <link>https://www.quantisnow.com/insight/whitehorse-finance-inc-to-redeem-7875-notes-due-2028-6791258</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/whitehorse-finance-inc-to-redeem-7875-notes-due-2028-6791258</guid>
      <pubDate>Fri, 13 Nov 2026 21:56:00 GMT</pubDate>
    </item>
    <item>
      <title>Service Properties Trust Receives Statement of Support from Shareholder Helix Partners Management LP</title>
      <description>
Service Properties Trust (NASDAQ:SVC) (&quot;SVC&quot; or the &quot;Company&quot;) today announced that Helix Partners Management LP (&quot;Helix Partners&quot;), SVC’s largest institutional shareholder, has issued a letter to SVC’s Board of Trustees (the &quot;Board&quot;) in support of the plan SVC’s Board has announced to transition SVC into a pure-play triple net lease REIT.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261113350409/en/
A copy of Helix Partners’ letter to SVC’s Board is available through the multimedia link accompanying this press release.


As previously announced, SVC plans to begin selling its 77 retained hotels in 2027 with the goal of sellin</description>
      <link>https://www.quantisnow.com/insight/service-properties-trust-receives-statement-of-support-from-shareholder-helix-6791239</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/service-properties-trust-receives-statement-of-support-from-shareholder-helix-6791239</guid>
      <pubDate>Fri, 13 Nov 2026 21:54:00 GMT</pubDate>
    </item>
    <item>
      <title>AtlasClear Holdings, Inc. Reports Fiscal First Quarter 2027 Results</title>
      <description>–First Quarter Revenue Increased 27% Year-over-Year to $5.4 Million; Revenue Plus Interest Income of $5.9 Million*–  –Stock Locate Revenue of $3.0 Million–  –Revenue from Sources Other Than Commissions Rose to 68% of Total Revenue, from 45%–  –AtlasClearing Net Capital Increased to $15.2 Million, $14.9 Million in Excess of Requirements–  –Definitive Agreement to Acquire Ark Financial Services Signed and FINRA Continuing Membership Application Filed; Correspondent Network Expanded to Nine Signed Agreements–  –Earnings Conference Call Scheduled for Monday, November 16, 2026, at 8:30 AM ET–  TAMPA, Fla., Nov.  13, 2026  (GLOBE NEWSWIRE) -- AtlasClear Holdings, Inc. (&quot;AtlasClear&quot; or the &quot;Company</description>
      <link>https://www.quantisnow.com/insight/atlasclear-holdings-inc-reports-fiscal-first-quarter-2027-results-6791224</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/atlasclear-holdings-inc-reports-fiscal-first-quarter-2027-results-6791224</guid>
      <pubDate>Fri, 13 Nov 2026 21:52:53 GMT</pubDate>
    </item>
    <item>
      <title>Seritage Growth Properties Reports Third Quarter 2026 Operating Results</title>
      <description>
Seritage Growth Properties (NYSE:SRG) (the &quot;Company&quot;), a national owner and developer of retail, residential and mixed-use properties today reported financial and operating results for the three and nine months ended September 30, 2026.


&quot;Although we have no new transactions under contract, we continue to work on both individual asset sales and potential strategic options for the portfolio and the Company,&quot; said Adam Metz, CEO &amp; President.


Q3 Sale Highlights:



Generated gross proceeds of $3.0 million from the sale of one vacant/non-income producing asset and received a distribution of $8.9 million from an unconsolidated entity as a result of the sale of a portion of the underlying prop</description>
      <link>https://www.quantisnow.com/insight/seritage-growth-properties-reports-third-quarter-2026-operating-results-6791202</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/seritage-growth-properties-reports-third-quarter-2026-operating-results-6791202</guid>
      <pubDate>Fri, 13 Nov 2026 21:50:00 GMT</pubDate>
    </item>
    <item>
      <title>Eagle Capital Growth Fund Declares Year-End Distribution of $0.49 Per Share</title>
      <description>
The Eagle Capital Growth Fund, Inc. (&quot;Fund&quot;) (NYSE:GRF) today declared a year-end distribution of $0.49 per share in cash. The record date for this distribution is November 27, 2026, and the payment date is December 17, 2026.


On a preliminary basis, this distribution represents a combination of net investment income of $0.055 per share and long-term capital gains of $0.435 per share. All of the net investment income consists of &quot;qualified&quot; dividends. This preliminary information is subject to change. Shareholders will receive definitive information with respect to U.S. Federal income tax treatment. In addition, shareholders can access definitive tax information by going to the Fund’s webs</description>
      <link>https://www.quantisnow.com/insight/eagle-capital-growth-fund-declares-year-end-distribution-of-049-per-6791185</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/eagle-capital-growth-fund-declares-year-end-distribution-of-049-per-6791185</guid>
      <pubDate>Fri, 13 Nov 2026 21:49:00 GMT</pubDate>
    </item>
    <item>
      <title>Tempest Reports Third Quarter 2026 Financial Results and Provides Business Update</title>
      <description>Exclusively licensed Senlang’s CD7-Targeted lentiviral in vivo CAR-T platform following initial Phase 1 results with lead BCMA/GPRC5D candidate TPST-4903  Secured access to additional capital through an equity line of credit with Lincoln Park Capital Fund of up to $50.0 million and a private placement with gross proceeds of approximately $2.5 million  Strengthened Board of Directors with the appointments of Nancy Freda-Smith and John W. Frederick   BRISBANE, Calif., Nov.  13, 2026  (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (NASDAQ:TPST) (&quot;Tempest&quot;), a clinical-stage biotechnology company developing a pipeline of advanced in vivo chimeric antigen receptor T-cell (&quot;CAR-T&quot;) product candida</description>
      <link>https://www.quantisnow.com/insight/tempest-reports-third-quarter-2026-financial-results-and-provides-business-6791175</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/tempest-reports-third-quarter-2026-financial-results-and-provides-business-6791175</guid>
      <pubDate>Fri, 13 Nov 2026 21:47:59 GMT</pubDate>
    </item>
    <item>
      <title>Cingulate Inc. Reports Third Quarter 2026 Financial Results and Provides Regulatory Update on CTx-1301 NDA Resubmission</title>
      <description>Manufacturing Work Addressing FDA CMC Information Requests Substantially Completed  NDA Resubmission Expected Between December 2026 and January 2027  KANSAS CITY, Kan., Nov.  13, 2026  (GLOBE NEWSWIRE) --  Cingulate Inc. (NASDAQ:CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform to develop a pipeline of next-generation products, today reported financial results for the quarter ended September 30, 2026, and announced that it has substantially completed the manufacturing work required to address the U.S. Food and Drug Administration’s (FDA) chemistry, manufacturing and controls (CMC) information requests for CTx-1301. The Company</description>
      <link>https://www.quantisnow.com/insight/cingulate-inc-reports-third-quarter-2026-financial-results-and-provides-6791148</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/cingulate-inc-reports-third-quarter-2026-financial-results-and-provides-6791148</guid>
      <pubDate>Fri, 13 Nov 2026 21:45:00 GMT</pubDate>
    </item>
    <item>
      <title>Xylem Inc. Announces $1.5 Billion Share Repurchase Authorization</title>
      <description>
Xylem Inc. (NYSE:XYL), a leading global water solutions company dedicated to solving the world’s most challenging water issues, today announced that its Board of Directors has authorized a new share repurchase program of its common stock of up to $1.5 billion, effective immediately. Repurchases may be made from time to time on the open market or in privately negotiated transactions. The Company intends to be opportunistic in its repurchases of stock based on market conditions and other factors, and may suspend or discontinue the repurchase program at any time.


&quot;Our strong financial position gives us the flexibility to invest in organic and inorganic growth while returning capital to share</description>
      <link>https://www.quantisnow.com/insight/xylem-inc-announces-15-billion-share-repurchase-authorization-6791147</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/xylem-inc-announces-15-billion-share-repurchase-authorization-6791147</guid>
      <pubDate>Fri, 13 Nov 2026 21:45:00 GMT</pubDate>
    </item>
    <item>
      <title>Westlake Corporation Declares Quarterly Dividend</title>
      <description>HOUSTON, Nov.  13, 2026  (GLOBE NEWSWIRE) -- The Board of Directors of Westlake Corporation (NYSE:WLK) today declared a regular dividend distribution of $0.533 per share for the third quarter of 2026. This dividend will be payable on December 10, 2026 to stockholders of record on November 24, 2026.  Westlake announced its first dividend on November 11, 2004 and has successively been paying and increasing its dividend for the past 22 years.  The statements in this release that are not historical facts, including statements regarding future payment of dividend, are forward-looking statements. These forward-looking statements are subject to significant risks and uncertainties. For more detailed</description>
      <link>https://www.quantisnow.com/insight/westlake-corporation-declares-quarterly-dividend-6791097</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/westlake-corporation-declares-quarterly-dividend-6791097</guid>
      <pubDate>Fri, 13 Nov 2026 21:40:00 GMT</pubDate>
    </item>
    <item>
      <title>XMax Inc. Announces Third Quarter 2026 Financial Results</title>
      <description>LOS ANGELES, Nov.  13, 2026  (GLOBE NEWSWIRE) -- XMax Inc. (NASDAQ:XMAX, &quot;XMAX&quot; or the &quot;Company&quot;)), a distributor of contemporary furniture and artificial intelligence software and platform-based service provider, today announced financial results for the third quarter ended September 30, 2026.  Third Quarter 2026 Financial Highlights  Revenue: $6.4 million, down 34% from $9.8 million in the third quarter of 2025, including $4.5 million from API-based services and $1.9 million from furniture (down 81%, as the prior-year period included a $7.9 million marble slab liquidation sale)Gross Profit: $0.9 million, representing a 14% gross margin, compared to gross profit of $1.0 million and gross ma</description>
      <link>https://www.quantisnow.com/insight/xmax-inc-announces-third-quarter-2026-financial-results-6791044</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/xmax-inc-announces-third-quarter-2026-financial-results-6791044</guid>
      <pubDate>Fri, 13 Nov 2026 21:35:00 GMT</pubDate>
    </item>
    <item>
      <title>Sysco Declares Quarterly Dividend Payment</title>
      <description>HOUSTON, Nov.  13, 2026  (GLOBE NEWSWIRE) -- Sysco Corporation (NYSE:SYY) today announced that the Board of Directors declared a quarterly cash dividend of $0.55 per share, payable on January 29, 2027, to common stockholders of record at the close of business on January 8, 2027.  About Sysco  Sysco is the global leader in selling, marketing and distributing food and related products to customers who prepare meals away from home. This includes restaurants, healthcare and educational facilities, lodging establishments, entertainment venues, and more. Sysco operates 333 distribution centers, in 10 countries, with 75,000 colleagues serving approximately 670,000 customer locations. The company ge</description>
      <link>https://www.quantisnow.com/insight/sysco-declares-quarterly-dividend-payment-6791043</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/sysco-declares-quarterly-dividend-payment-6791043</guid>
      <pubDate>Fri, 13 Nov 2026 21:35:00 GMT</pubDate>
    </item>
    <item>
      <title>Zai Lab Announces Participation in Investor Conferences in November 2026</title>
      <description>
Zai Lab Limited (NASDAQ:ZLAB, HKEX: 9688)) today announced that members of the Company’s senior management team will participate in the following investor conferences in November 2026:


UBS Global Biopharma Conference
Date: November 17, 2026
Event Format: 1-on-1 meetings only
Location: London, UK


Jefferies Global Healthcare Conference in London
Date: November 18 and 19, 2026
Fireside Chat: Wednesday, November 18, 2026 at 10:30AM GMT
Event Format: Presentation and 1-on-1 meetings
Location: London, UK


Live webcasts will be available on the Investor Relations page of Zai Lab’s website at ir.zailaboratory.com/webcasts-presentations and archived replays will be available for up to 90 days f</description>
      <link>https://www.quantisnow.com/insight/zai-lab-announces-participation-in-investor-conferences-in-november-2026-6791042</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/zai-lab-announces-participation-in-investor-conferences-in-november-2026-6791042</guid>
      <pubDate>Fri, 13 Nov 2026 21:35:00 GMT</pubDate>
    </item>
    <item>
      <title>Parabolic Technologies, Inc. to Host Third Quarter 2026 Financial Results Conference Call on Monday, November 16, 2026 at 4:30 p.m. Eastern Time</title>
      <description>SEATTLE, Nov.  13, 2026  (GLOBE NEWSWIRE) -- Parabolic Technologies, Inc. (NASDAQ:PARA) (the &quot;Company&quot;), a leading AI-powered agentic applications technology company, will hold a conference call on Monday, November 16, 2026, at 4:30 p.m. Eastern Time to discuss its financial results for the third quarter ended September 30, 2026, as well as review ongoing initiatives and anticipated milestones.    Parabolic Founder and CEO Joe Davy and CFO Dean Ditto will host the conference call, followed by a question-and-answer session. The conference call will be accompanied by a presentation, which can be viewed during the webcast or accessed via the investor relations section of the Company’s website h</description>
      <link>https://www.quantisnow.com/insight/parabolic-technologies-inc-to-host-third-quarter-2026-financial-results-6790967</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/parabolic-technologies-inc-to-host-third-quarter-2026-financial-results-6790967</guid>
      <pubDate>Fri, 13 Nov 2026 21:32:43 GMT</pubDate>
    </item>
    <item>
      <title>Yiren Digital Receives NYSE Notification Regarding Stock Price Requirement</title>
      <description>BEIJING, Nov. 13, 2026 /PRNewswire/ -- Yiren Digital Ltd. (NYSE:YRD) (&quot;Yiren Digital&quot; or the &quot;Company&quot;), a leading company specializing in financial technology and artificial intelligence innovation across multiple industries in China and global markets, today announced that it received a letter dated October 20, 2026, from the New York Stock Exchange (the &quot;NYSE&quot;) notifying the Company that it was not in compliance with the NYSE&apos;s continued listing standard under Section 802.01C of the NYSE Listed Company Manual (the &quot;Price Criteria&quot;) for the average closing price of the Company&apos;s American depositary shares (the &quot;ADSs&quot;) was below US$1.00 per ADS over a consecutive 30-trading-day period.
The </description>
      <link>https://www.quantisnow.com/insight/yiren-digital-receives-nyse-notification-regarding-stock-price-requirement-6790900</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/yiren-digital-receives-nyse-notification-regarding-stock-price-requirement-6790900</guid>
      <pubDate>Fri, 13 Nov 2026 21:30:00 GMT</pubDate>
    </item>
  </channel>
</rss>